A number of studies have shown that patients with mutations in the STAT3 gene are more likely to develop RA than patients without these mutations (Jerez et al., 2012; Koskela et al., 2012; Shi et al., 2018). This evidence concerns the gene STAT3 and rheumatoid arthritis.